A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Sponsor: Gilead Sciences
Terminated
The study stopped early because the study objectives were met.
Other terminated trials from Gilead Sciences
Other Hepatitis C Virus Infection trials with similar outcome
Listed as NCT02510300, this observational or N/A phase trial focuses on Hepatitis C Virus Infection and remains terminated or withdrawn. Sponsored by Gilead Sciences, it has been updated 38 times since 2015, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
38 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Feb 2023 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting
▶ Show 33 earlier versions
-
Feb 2022 — Sep 2022 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Enrolling By Invitation
-
Dec 2021 — Jan 2022 [monthly]
Enrolling By Invitation
-
Nov 2021 — Dec 2021 [monthly]
Enrolling By Invitation
-
Oct 2021 — Nov 2021 [monthly]
Enrolling By Invitation
-
Sep 2021 — Oct 2021 [monthly]
Enrolling By Invitation
-
Jun 2021 — Sep 2021 [monthly]
Enrolling By Invitation
-
Apr 2021 — Jun 2021 [monthly]
Enrolling By Invitation
-
Feb 2021 — Apr 2021 [monthly]
Enrolling By Invitation
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Nov 2020 — Dec 2020 [monthly]
Enrolling By Invitation
-
Oct 2020 — Nov 2020 [monthly]
Enrolling By Invitation
-
Sep 2020 — Oct 2020 [monthly]
Enrolling By Invitation
-
Aug 2020 — Sep 2020 [monthly]
Enrolling By Invitation
-
Jun 2020 — Aug 2020 [monthly]
Enrolling By Invitation
-
Apr 2020 — Jun 2020 [monthly]
Enrolling By Invitation
-
Mar 2020 — Apr 2020 [monthly]
Enrolling By Invitation
-
Oct 2019 — Mar 2020 [monthly]
Enrolling By Invitation
-
May 2019 — Oct 2019 [monthly]
Enrolling By Invitation
-
Apr 2019 — May 2019 [monthly]
Enrolling By Invitation
-
Mar 2019 — Apr 2019 [monthly]
Enrolling By Invitation
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation
-
Nov 2018 — Feb 2019 [monthly]
Enrolling By Invitation
-
Jul 2018 — Nov 2018 [monthly]
Enrolling By Invitation
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Enrolling By Invitation NA
-
Oct 2017 — Dec 2017 [monthly]
Enrolling By Invitation NA
-
Aug 2017 — Oct 2017 [monthly]
Enrolling By Invitation NA
-
Feb 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gilead Sciences
For direct contact, visit the study record on ClinicalTrials.gov .